“BMI and TLC Influences Doxorubicin Epirubicin Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer”. 2022. Majalah Kedokteran Bandung 54 (4): 221-27. https://doi.org/10.15395/mkb.v54n4.2797.